These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 3280003)

  • 1. Enrichment of haemopoietic progenitor cells from the marrow of patients with myelodysplasia.
    Baines P; Masters GS; Lush C; Jacobs A
    Br J Haematol; 1988 Feb; 68(2):159-64. PubMed ID: 3280003
    [TBL] [Abstract][Full Text] [Related]  

  • 2. In vitro growth of myeloid and erythroid progenitor cells from myelodysplastic patients in response to recombinant human granulocyte-macrophage colony-stimulating factor.
    Mayani H; Baines P; Bowen DT; Jacobs A
    Leukemia; 1989 Jan; 3(1):29-32. PubMed ID: 2642575
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Enrichment of progenitor cells from human marrow.
    Baines P; Masters G; Booth M; Jacobs A
    Exp Hematol; 1987 Aug; 15(7):809-13. PubMed ID: 3609184
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Blast colony-forming cells in myelodysplastic syndrome: decreased potential to generate erythroid precursors.
    Backx B; Broeders L; Touw I; Löwenberg B
    Leukemia; 1993 Jan; 7(1):75-9. PubMed ID: 8418382
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Growth analysis of marrow CD34-positive hematopoietic progenitor cells in patients with myelodysplastic syndromes.
    Asano H; Hotta T; Ichihara M; Murate T; Kobayashi M; Saito H
    Leukemia; 1994 May; 8(5):833-8. PubMed ID: 7514249
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Regulatory abnormalities in the marrow of patients with myelodysplastic syndromes.
    Merchav S; Nagler A; Fleischer-Kurtz G; Tatarsky I
    Br J Haematol; 1989 Oct; 73(2):158-64. PubMed ID: 2479408
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Impaired response of myelodysplastic marrow progenitors to stimulation with recombinant haemopoietic growth factors.
    Merchav S; Wagemaker G; Souza LM; Tatarsky I
    Leukemia; 1991 Apr; 5(4):340-6. PubMed ID: 1709245
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Megakaryocyte, erythroid and granulocyte-macrophage colony formation in myelodysplastic syndromes.
    Dan K; An E; Futaki M; Inokuchi K; Gomi S; Yamada T; Ogata K; Tanabe Y; Ohki I; Shinohara T
    Acta Haematol; 1993; 89(3):113-8. PubMed ID: 8362599
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mast cell growth factor (c-kit ligand) restores growth of multipotent progenitors in myelodysplastic syndrome.
    Glinsmann-Gibson B; Spier C; Baier M; Taetle R; Broudy VC; List AF
    Leukemia; 1994 May; 8(5):827-32. PubMed ID: 7514248
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Enrichment of CD34 (My10)-positive myeloid and erythroid progenitors from human marrow and their growth in cultures supplemented with recombinant human granulocyte-macrophage colony-stimulating factor.
    Baines P; Mayani H; Bains M; Fisher J; Hoy T; Jacobs A
    Exp Hematol; 1988 Oct; 16(9):785-9. PubMed ID: 2458955
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hematopoietic progenitor cells from patients with myelodysplastic syndromes: in vitro colony growth and long-term proliferation.
    Flores-Figueroa E; Gutiérrez-Espindola G; Guerrero-Rivera S; Pizzuto-Chavez J; Mayani H
    Leuk Res; 1999 Apr; 23(4):385-94. PubMed ID: 10229325
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Erythroid and myeloid maturation patterns related to progenitor assessment in the myelodysplastic syndromes.
    Dörmer P; Schalhorn A; Wilmanns W; Hershko C
    Br J Haematol; 1987 Sep; 67(1):61-6. PubMed ID: 3663522
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Functional studies of bone marrow haemopoietic and stromal cells in the myelodysplastic syndrome (MDS).
    Coutinho LH; Geary CG; Chang J; Harrison C; Testa NG
    Br J Haematol; 1990 May; 75(1):16-25. PubMed ID: 2375919
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Abnormalities of adherent layers grown from bone marrow of patients with myelodysplasia.
    Tennant GB; Walsh V; Truran LN; Edwards P; Mills KI; Burnett AK
    Br J Haematol; 2000 Dec; 111(3):853-62. PubMed ID: 11122147
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A practical miniature long-term bone marrow culture system for investigating early myelodysplasia.
    Roberts IA; McMullin MF
    Leuk Res; 1992 Aug; 16(8):737-41. PubMed ID: 1528061
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of culture conditions on in vitro erythroid colony formation in myelodysplastic syndromes.
    Juvonen E; Ruutu T
    Exp Hematol; 1990 Nov; 18(10):1070-2. PubMed ID: 2209760
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Bone marrow cultures in dysmyelopoietic syndrome: diagnostic and prognostic evaluation.
    Shihab-el-Deen A; Guevara C; Prchal JF
    Acta Haematol; 1987; 78(1):17-22. PubMed ID: 3116803
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Differential responses of myeloid progenitor cells from patients with myeloid leukemia and myelodysplasia to the costimulating effects of steel factor in vitro.
    Maze R; Horie M; Hendrie P; Vadhan-Raj S; Tricot G; Gordon M; Nemunaitis J; Ashman LK; Broxmeyer HE
    Exp Hematol; 1993 Apr; 21(4):545-51. PubMed ID: 7681784
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Myeloid progenitors from the bone marrow of patients with vitamin D resistant rickets (type II) fail to respond to 1,25(OH)2D3.
    Nagler A; Merchav S; Fabian I; Tatarsky I; Weisman Y; Hochberg Z
    Br J Haematol; 1987 Nov; 67(3):267-71. PubMed ID: 2825755
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of the differentiating agent hexamethylene bisacetamide on normal and myelodysplastic hematopoietic progenitors.
    Rowinsky EK; Donehower RC; Spivak JL; Burke PJ; Griffin CA; Jones RJ
    J Natl Cancer Inst; 1990 Dec; 82(24):1926-31. PubMed ID: 2250314
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.